SCHEMBL28781507

SCHEMBL28781507

COC(=O)c1cccnc1-c1[nH]c2ccccc2c1OC(=O)C(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 1/20 0.45
▸ NR4A2 P43354 3/20 0.42
▸ CREBBP Q92793 1/20 0.42
▸ IDO1 P14902 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ GABRA1 P14867 2/20 0.40
▸ GABRG2 P18507 2/20 0.40
▸ GABRB3 P28472 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ PKM P14618 2/20 0.40
▸ GABRP O00591 1/20 0.40
▸ GABRD O14764 1/20 0.40
▸ PDE5A O76074 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GABRB1 P18505 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19748380 0.78 CHEK1 (0.45) NR4A2IDO1PTPN1KDM4EGABRA1
SCHEMBL19988801 0.72 KDM4E (0.47) MAP2K1NR4A2CREBBPIDO1PTPN1
SCHEMBL29520873 0.71 KDM4E (0.45) MAP2K1NR4A2CREBBPKDM4EGABRA1
SCHEMBL812065 0.71 KDM4E (0.59) MAP2K1KDM4ELMNAPKMALDH1A1
SCHEMBL27918837 0.70 NR4A2 (0.49) NR4A2KDM4EGABRA1GABRG2GABRB3
SCHEMBL11117588 0.69 TUBB4A (0.51) KDM4EALDH1A1CYP1A2CYP3A4MAPT
SCHEMBL3834924 0.69 NR4A2 (0.49) MAP2K1NR4A2KDM4EPKMALDH1A1
SCHEMBL27312758 0.69 KDM4E (0.57) KDM4ELMNAPKMALDH1A1MAPT
SCHEMBL11119591 0.69 CHEK1 (0.41) NR4A2KDM4EGABRA1GABRG2GABRB3
SCHEMBL11122004 0.68 CHEK1 (0.43) NR4A2IDO1PTPN1KDM4EGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101578100-A Use of neuroprotective compounds for obtaining drugs for treating neurodegenerative diseases SERVIER LAB (FR) 2009-11-11 — — CN disclosed
Send feedback